ArticleZeitschrift fur Gerontologie und Geriatrie2019
Association between EU guidelines and vaccination in Germany between 2011 and 2017 : How healthcare legislation of the EU has influenced access to vaccination for senior citizens in Germany since 2011.
Article in Zeitschrift fur Gerontologie und Geriatrie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvery fourth citizen within the 28 European Union (EU) member states is over the age of 65 years. In connection with the increasing numbers of senior citizens, vaccinations have become even more important as preventive measures. Vaccines are an established preventive measure and help to ensure that many diseases no longer have a fatal outcome. With respect to the health economic as well as preventive advantages of vaccines, there is possibly a considerable benefit for the EU to support the vaccination program for older patients within the framework of the demographic shift. Since 2011 the EU addresses the demographic change and has thereby placed the possible chances and risks on the agenda.
objectiveBy focussing on Germany as an EU member state, the question whether the EU guidelines had an influence on vaccination access for senior citizens in the years 2011-2017 was analyzed. It is discussed if a healthcare policy influence was pursued, regardless of not having a unified EU healthcare system. MATERIAL AND
methodsThe EUR-lex database was searched for relevant EU policies regarding vaccination and older patients between February 2011 and May 2017. Results were then discussed within four expert interviews, which were from industry, academia, politics and physician practice.
resultsOverall, four relevant EU policies since 2011 were selected. The discussion resolves that the initiative of the EU to promote the healthcare of senior citizens (EMA Geriatric Medicines Strategy) and the Clinical trials - Regulation EU from 2014 had a significant impact on vaccination access. Due to the EU national policies in Germany were initiated, which had an effect on national level to this specific risk group and vaccination access.
conclusionOther than expected, the EU has a passive influence on the healthcare policy transformation on a national level; however, it should be noted that initiatives in politics are always influenced by several impulses. Hereby, a deeper analysis should be considered, which includes the policy action campaigns by multinational stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.